UILLAIN-BARRÉ SYNDROME (GBS) is a peripheral neuropathy with acute onset and is characterized, in its typical presentation, by rapidly developing motor weakness and areflexia. 1,2 The disease is thought to be autoimmune and triggered by a stimulus of external origin. 1,2 In 1976-1977, an unusually high rate of GBS was identified in the United States following the administration of inactivated "swine" influenza A(H1N1) vaccines. 3 In 2003, the Institute of Medicine (IOM) concluded that the evidence favored acceptance of a causal relationship between the 1976 swine influenza vaccines and GBS in adults. 4 Studies of seasonal influenza vaccines administered in subsequent years have found small or no increased risk. 5 In mice, different influenza vaccines can induce antiganglioside antibodies that are associated with the development of GBS in humans. 6 Extrapolation of results of animal studies to humans, however, is